Published June 2021 | Version v1
Journal article

A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer

  • 1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong (China)
  • 2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong (China)
  • 3. Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong (China)
  • 4. Guangzhou Darui Biotechnology Co, Ltd High-Tech Development Zone, Guangzhou, Guangdong (China)
  • 5. Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong (China)
  • 6. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong (China)

Description

To construct and validate a predicting genotype signature for pathologic complete response (pCR) in locally advanced rectal cancer (PGS-LARC) after neoadjuvant chemoradiation.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2021.01.005

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2021.01.005;
PII
S0360301621000079;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
110
Journal Issue
2
Journal Page Range
p. 482-491
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124489
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
GENOTYPE; NEOPLASMS; POLYMERASE CHAIN REACTION; RADIOTHERAPY; RECTUM
Descriptors DEC
BODY; DIGESTIVE SYSTEM; DISEASES; GASTROINTESTINAL TRACT; GENE AMPLIFICATION; INTESTINES; LARGE INTESTINE; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.